From January 12, 2024 to January 15, 2024, the company has repurchased 160,000 shares, representing 0.93% for ¥303.36 million. With this, the company has completed the repurchase of 160,000 shares, representing 0.93% for ¥303.36 million under the buyback announced on January 12, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,518 JPY | +1.12% | +2.23% | +32.18% |
Apr. 12 | Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 350,000 shares, representing 2.23% for ¥1,000 million. | CI |
Apr. 12 | Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.18% | 250M | |
+20.65% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+12.64% | 13.64B | |
+38.68% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- 4577 Stock
- News Daito Pharmaceutical Co.,Ltd.
- Tranche Update on Daito Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 12, 2024.